VAXX — Vaxxinity Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Vaxxinity Announces First Participant Dosed In Phase 3 Study Of Next-Generation Covid-19 Vaccine Booster
Brief: Vaxxinity Reports Fourth Quarter And Full-Year 2021 Financial Results And Provides Corporate Updates
Brief: Vaxxinity Appoints Dr. Peter Powchik To Board Of Directors
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
Brief: Vaxxinity Announces First Parkinson’S Disease Patient Dosed In Part B Of Phase 1 Clinical Trial Of Ub-312
Brief: Vaxxinity Awarded Grant From The Michael J. Fox Foundation For Parkinson’S Research
Brief: Vaxxinity Inc - On January 3, Board Increased Size Of Board From Five Members To Six
Brief: Vaxxinity Reports Third Quarter 2021 Financial Results And Provides Corporate Updates
Vaxxinity jumps as Jefferies initiates coverage with 'buy' rating
Biotech firm Vaxxinity soars in market debut
Brief: Vaxxinity Inc Class A Shares Open About 30% Above IPO Price in Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:40 AM
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:38 AM
Brief: Vaxxinity Announces Pricing Of Initial Public Offering
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 01:01 PM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Vaxxinity Inc Sees IPO Of Up To 6.7 Mln Shares Of Class A Common Stock Priced To Be Between $14 And $16 Per Share